Nombre del Modulo |
1.2.1.3 Libro científico |
Titulo |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Subtitulo |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Colección |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Número de Páginas |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Edición |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
ISBN |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Pais |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Idioma |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Editorial |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Tiraje |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Fecha de Aceptación |
0000-00-00 |
Fecha de Publicación |
0000-00-00 |
Coautores |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Año de la Actividad |
2015 |
Observaciones |
Did you go to university? http://nhentai.in.net/ nhentai.com Xeljanz, approved last November for rheumatoid arthritis,had second quarter sales of $22 million. But some industryanalysts expect it to eventually capture annual sales of $1billion or more, as |
Proyecto de Investigacion Asignado |
|